Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex
Open Access
- 2 June 1995
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 192 (1) , 53-56
- https://doi.org/10.1016/0304-3940(95)11608-y
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatumBrain Research, 1994
- Ibogaine reduces preference for cocaine consumption in C57BL/6By micePharmacology Biochemistry and Behavior, 1994
- L-name and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaineLife Sciences, 1993
- Effect of D-cycloserine on rapid tolerance to ethanolPharmacology Biochemistry and Behavior, 1993
- Ibogaine antagonizes cocaine-induced locomotor stimulation in miceLife Sciences, 1992
- Effects of ibogaine on acute signs of morphine withdrawal in rats: Independence from tremorNeuropharmacology, 1992
- Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in ratsBrain Research, 1992
- Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801Science, 1991
- Mechanisms of blockade of excitatory amino acid receptor channelsTrends in Pharmacological Sciences, 1990
- Blockade of “reverse tolerance” to cocaine and amphetamine by MK-801Life Sciences, 1989